NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 220 filers reported holding NOVAVAX INC in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $296,000 | -28.0% | 42,684 | +6.7% | 0.00% | -50.0% |
| Q4 2022 | $411,000 | -42.4% | 40,004 | +2.1% | 0.00% | -33.3% |
| Q3 2022 | $713,000 | -64.3% | 39,166 | +0.8% | 0.00% | -62.5% |
| Q2 2022 | $1,998,000 | -30.7% | 38,857 | -0.8% | 0.01% | -20.0% |
| Q1 2022 | $2,885,000 | -51.3% | 39,174 | -5.5% | 0.01% | -50.0% |
| Q4 2021 | $5,929,000 | -31.8% | 41,441 | -1.2% | 0.02% | -35.5% |
| Q3 2021 | $8,697,000 | -5.2% | 41,951 | -2.9% | 0.03% | -3.1% |
| Q2 2021 | $9,175,000 | +8984.2% | 43,217 | +7686.8% | 0.03% | – |
| Q1 2021 | $101,000 | – | 555 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
| Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
| Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
| Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
| Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
| TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
| Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
| SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |